Carbon nanospheres mediated nuclear delivery of SMAR1 protein (DNA binding domain) controls breast tumor in mice model

被引：3
|
作者：
Bhagat, Prasad N. [1 ]
Jadhav, Sachin H. [1 ]
Chattopadhyay, Samit [2 ,3 ]
Paknikar, Kishore M. [1 ]
机构：
[1] Agharkar Res Inst, GG Agarkar Rd, Pune 411004, Maharashtra, India
[2] Natl Ctr Cell Sci, SP Pune Univ Campus,Ganeshkhind Rd, Pune 411007, Maharashtra, India
[3] Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, India
来源：
NANOMEDICINE | 2018年 / 13卷 / 04期
关键词：
breast cancer; carbon nanospheres; DNA binding domain; PET; SMAR1; MESOPOROUS SILICA NANOPARTICLES; SOLID LIPID NANOPARTICLES; CANCER-THERAPY; IN-VIVO; P53; PEPTIDE; GROWTH; CELLS; THERAPEUTICS; METASTASIS;
D O I：
10.2217/nnm-2017-0298
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To investigate anticancer activity of the DNA binding domain of SMAR1 (His 5) in vitro and in vivo. Materials & methods: His 5 was conjugated to hydrothermally synthesized carbon nanospheres (CNs). Anticancer activity of CNs-His 5 was evaluated in vitro and in vivo. Results: CNs-His 5 significantly reduced cyclin D1 levels in MDA-MB-231 cells. Tumor bearing Balb/c mice injected with CNs-His 5 showed approximately 62% tumor regression and significantly reduced (18)FDG uptake. Caspases assay and IHC staining confirmed tumor growth inhibition, which could be attributed to apoptotic, antiproliferative and antiangiogenic activities of His 5. Conclusion: DNA binding domain of the SMAR1 protein (His 5) has potent anticancer activity and its CNs mediated delivery could control breast tumor in mice model.
引用
收藏
页码：353 / 372
页数：20
相关论文
共 50 条
  • [31] CCAAT/Enhancer-Binding Protein ε27 Antagonism of GATA-1 Transcriptional Activity in the Eosinophil Is Mediated by a Unique N-Terminal Repression Domain, Is Independent of Sumoylation and Does Not Require DNA Binding
    Stankiewicz, Monika J.
    Du, Jian
    Martinico, Dominick
    Ackerman, Steven J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [32] Nuclear localization of intracellular domain of LDL receptor -related protein 1B predicts poor outcome in breast cancer; putative relation to NEAT1 mediated mammary gland carcinogenesis
    Asano, Y.
    Futamura, M.
    Takeuchi, T.
    Yoshida, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [33] CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells
    Sommerkamp, Pia
    Sommerkamp, Alexander C.
    Zeisberger, Petra
    Eiben, Paula Leonie
    Narr, Andreas
    Korkmaz, Aylin
    Przybylla, Adriana
    Sohn, Markus
    van der Hoeven, Franciscus
    Schoenig, Kai
    Trumpp, Andreas
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells
    Pia Sommerkamp
    Alexander C. Sommerkamp
    Petra Zeisberger
    Paula Leonie Eiben
    Andreas Narr
    Aylin Korkmaz
    Adriana Przybylla
    Markus Sohn
    Franciscus van der Hoeven
    Kai Schönig
    Andreas Trumpp
    Scientific Reports, 12
  • [35] Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue
    Ueno, Takato
    Torimura, Takuji
    Nakamura, Toru
    Sivakumar, Ramadoss
    Nakayama, Hitomi
    Otabe, Syuichi
    Yuan, Xiaohong
    Yamada, Kentaro
    Hashimoto, Osamu
    Inoue, Kinya
    Koga, Hironori
    Sata, Michio
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (01) : 17 - 22
  • [36] CCAAT/enhancer-binding protein ε27 antagonism of GATA-1 transcriptional activity is mediated by a unique N-terminal repression domain, is independent of sumoylation, and does not require but is enhanced by DNA-binding.
    Stankiewicz, MJ
    Du, J
    Ackerman, SJ
    BLOOD, 2004, 104 (11) : 411A - 411A
  • [37] CLONING AND CHARACTERIZATION OF A 3T3-L1 ADIPOCYTE CDNA-ENCODING A NUCLEAR-PROTEIN THAT CONTAINS A NOVEL SEQUENCE-SPECIFIC DNA-BINDING DOMAIN
    MCGEHEE, RE
    HABENER, JF
    CLINICAL RESEARCH, 1993, 41 (02): : A202 - A202
  • [38] Recruitment of TATA-binding protein-TAF, complex SL1 to the human ribosomal DNA promoter is mediated by the carboxy-terminal activation domain of upstream binding factor (UBF) and is regulated by UBF phosphorylation
    Tuan, JC
    Zhai, WG
    Comai, L
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (04) : 2872 - 2879
  • [39] Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain
    Sakamoto, Y
    Yoshida, M
    Semba, K
    Hunter, T
    ONCOGENE, 1997, 15 (17) : 2001 - 2012
  • [40] Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain
    Yoshimasa Sakamoto
    Mitsuaki Yoshida
    Kentaro Semba
    Tony Hunter
    Oncogene, 1997, 15 : 2001 - 2012
12345